KAPA

KAIROS PHARMA LTD

KAPA·48301N104·US·Common Stock·Healthcare - Biotechnology-13D/G

KAPA (KAIROS PHARMA LTD) is held by 8 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($129,620), GEODE CAPITAL MANAGEMENT, LLC ($62,210), VANGUARD FIDUCIARY TRUST CO ($35,711). Net institutional sentiment: Mixed.

8
Holders
Avg rating(2 Elite)
$287,892
Total Value
45% (13)
Fund Consensus
5 buying - 6 selling
KAPASmart Money Verdict
View all
Held by 8 funds
2 elite
Who's Trading
ActivistARArmistice Capital, LLC5.0%Aug 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
231,878$129,6200.0%-43.55%
34
Increased
111,290(+52.8%)$62,2100.0%-60.15%
20
New
63,884$35,7110.0%-43.55%
30
Unchanged
44,286$24,7560.0%-61.96%
0
Decreased
39,543(-57.9%)$22,1050.0%-61.31%
0
Unchanged
24,100$13,4720.0%-68.75%
0
Increased
21,575(+1.2%)$120.0%-49.94%
8
New
10$60.0%-43.55%
17
Exited
0(-100.0%)$9,2610.0%-11.43%
0
Exited
0(-100.0%)$34,4310.0%-10.45%
0
Exited
0(-100.0%)$14,0000.0%-11.43%
0
Exited
0(-100.0%)$228,4340.0%-11.43%
0
Exited
0(-100.0%)$950.0%-43.07%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used